Urine tenascin‑C is an independent risk factor for bladder cancer patients.


Urine biomarkers offer a non‑invasive method of detecting bladder cancer, monitoring disease progression and predicting disease recurrence and therapeutic treatment efficacy. Tenascin‑C (TN‑C), as a component of the extracellular matrix, is vital in the progression of bladder cancer. However, there is little to report with regard to urine TN‑C and its… (More)
DOI: 10.3892/mmr.2013.1873


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics